nodes	percent_of_prediction	percent_of_DWPC	metapath
Bendroflumethiazide—Allergic cutaneous angiitis—Indinavir—acquired immunodeficiency syndrome	0.023	0.0323	CcSEcCtD
Bendroflumethiazide—CA1—nerve—acquired immunodeficiency syndrome	0.0188	0.0656	CbGeAlD
Bendroflumethiazide—Leukocytoclastic vasculitis—Indinavir—acquired immunodeficiency syndrome	0.0149	0.0209	CcSEcCtD
Bendroflumethiazide—CA4—nerve—acquired immunodeficiency syndrome	0.0147	0.0513	CbGeAlD
Bendroflumethiazide—CA1—blood plasma—acquired immunodeficiency syndrome	0.0142	0.0496	CbGeAlD
Bendroflumethiazide—Leukocytoclastic vasculitis—Delavirdine—acquired immunodeficiency syndrome	0.0135	0.0189	CcSEcCtD
Bendroflumethiazide—Blood disorder—Didanosine—acquired immunodeficiency syndrome	0.0125	0.0175	CcSEcCtD
Bendroflumethiazide—Drug interaction—Didanosine—acquired immunodeficiency syndrome	0.0112	0.0158	CcSEcCtD
Bendroflumethiazide—TPMT—retina—acquired immunodeficiency syndrome	0.011	0.0384	CbGeAlD
Bendroflumethiazide—Blood disorder—Stavudine—acquired immunodeficiency syndrome	0.0108	0.0152	CcSEcCtD
Bendroflumethiazide—Blood disorder—Abacavir—acquired immunodeficiency syndrome	0.0107	0.015	CcSEcCtD
Bendroflumethiazide—KCNMA1—retina—acquired immunodeficiency syndrome	0.0102	0.0358	CbGeAlD
Bendroflumethiazide—Drug interaction—Nevirapine—acquired immunodeficiency syndrome	0.0101	0.0142	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Amprenavir—acquired immunodeficiency syndrome	0.00955	0.0134	CcSEcCtD
Bendroflumethiazide—CA2—blood plasma—acquired immunodeficiency syndrome	0.00921	0.0321	CbGeAlD
Bendroflumethiazide—Diabetes mellitus—Didanosine—acquired immunodeficiency syndrome	0.0087	0.0122	CcSEcCtD
Bendroflumethiazide—SLC12A3—lung—acquired immunodeficiency syndrome	0.00869	0.0303	CbGeAlD
Bendroflumethiazide—Drug interaction—Zidovudine—acquired immunodeficiency syndrome	0.00848	0.0119	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Nelfinavir—acquired immunodeficiency syndrome	0.00758	0.0106	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Stavudine—acquired immunodeficiency syndrome	0.00756	0.0106	CcSEcCtD
Bendroflumethiazide—TPMT—blood—acquired immunodeficiency syndrome	0.00736	0.0257	CbGeAlD
Bendroflumethiazide—Drug interaction—Delavirdine—acquired immunodeficiency syndrome	0.00713	0.01	CcSEcCtD
Bendroflumethiazide—TPMT—bone marrow—acquired immunodeficiency syndrome	0.00713	0.0249	CbGeAlD
Bendroflumethiazide—Urine output increased—Zidovudine—acquired immunodeficiency syndrome	0.00712	0.00997	CcSEcCtD
Bendroflumethiazide—TPMT—spinal cord—acquired immunodeficiency syndrome	0.00709	0.0248	CbGeAlD
Bendroflumethiazide—TPMT—vagina—acquired immunodeficiency syndrome	0.00683	0.0238	CbGeAlD
Bendroflumethiazide—Blood disorder—Lamivudine—acquired immunodeficiency syndrome	0.00673	0.00943	CcSEcCtD
Bendroflumethiazide—Drug interaction—Ritonavir—acquired immunodeficiency syndrome	0.0066	0.00924	CcSEcCtD
Bendroflumethiazide—Gout—Ritonavir—acquired immunodeficiency syndrome	0.00655	0.00918	CcSEcCtD
Bendroflumethiazide—Polyuria—Zidovudine—acquired immunodeficiency syndrome	0.00651	0.00912	CcSEcCtD
Bendroflumethiazide—TPMT—lung—acquired immunodeficiency syndrome	0.00646	0.0225	CbGeAlD
Bendroflumethiazide—Pancreatitis—Didanosine—acquired immunodeficiency syndrome	0.00642	0.00899	CcSEcCtD
Bendroflumethiazide—Drug interaction—Saquinavir—acquired immunodeficiency syndrome	0.00635	0.0089	CcSEcCtD
Bendroflumethiazide—Urine output increased—Efavirenz—acquired immunodeficiency syndrome	0.00625	0.00876	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Indinavir—acquired immunodeficiency syndrome	0.00611	0.00856	CcSEcCtD
Bendroflumethiazide—Drug interaction—Lamivudine—acquired immunodeficiency syndrome	0.00606	0.00849	CcSEcCtD
Bendroflumethiazide—KCNMA1—lung—acquired immunodeficiency syndrome	0.00601	0.021	CbGeAlD
Bendroflumethiazide—Urine output increased—Delavirdine—acquired immunodeficiency syndrome	0.00598	0.00838	CcSEcCtD
Bendroflumethiazide—TPMT—nervous system—acquired immunodeficiency syndrome	0.00598	0.0209	CbGeAlD
Bendroflumethiazide—Cramp muscle—Nelfinavir—acquired immunodeficiency syndrome	0.00594	0.00832	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Nevirapine—acquired immunodeficiency syndrome	0.00577	0.00808	CcSEcCtD
Bendroflumethiazide—TPMT—central nervous system—acquired immunodeficiency syndrome	0.00576	0.0201	CbGeAlD
Bendroflumethiazide—Polyuria—Efavirenz—acquired immunodeficiency syndrome	0.00572	0.00801	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00559	0.00783	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Stavudine—acquired immunodeficiency syndrome	0.00557	0.00781	CcSEcCtD
Bendroflumethiazide—KCNMA1—nervous system—acquired immunodeficiency syndrome	0.00556	0.0194	CbGeAlD
Bendroflumethiazide—Urine output increased—Ritonavir—acquired immunodeficiency syndrome	0.00553	0.00775	CcSEcCtD
Bendroflumethiazide—CA1—lymphoid tissue—acquired immunodeficiency syndrome	0.00553	0.0193	CbGeAlD
Bendroflumethiazide—Pancreatitis—Abacavir—acquired immunodeficiency syndrome	0.00549	0.00769	CcSEcCtD
Bendroflumethiazide—Polyuria—Delavirdine—acquired immunodeficiency syndrome	0.00547	0.00767	CcSEcCtD
Bendroflumethiazide—CA1—digestive system—acquired immunodeficiency syndrome	0.00546	0.0191	CbGeAlD
Bendroflumethiazide—Vascular purpura—Delavirdine—acquired immunodeficiency syndrome	0.00537	0.00752	CcSEcCtD
Bendroflumethiazide—KCNMA1—central nervous system—acquired immunodeficiency syndrome	0.00536	0.0187	CbGeAlD
Bendroflumethiazide—CA1—blood—acquired immunodeficiency syndrome	0.0052	0.0182	CbGeAlD
Bendroflumethiazide—Diabetes mellitus—Ritonavir—acquired immunodeficiency syndrome	0.00511	0.00716	CcSEcCtD
Bendroflumethiazide—Urine output increased—Lamivudine—acquired immunodeficiency syndrome	0.00508	0.00712	CcSEcCtD
Bendroflumethiazide—Polyuria—Ritonavir—acquired immunodeficiency syndrome	0.00506	0.00709	CcSEcCtD
Bendroflumethiazide—Thirst—Delavirdine—acquired immunodeficiency syndrome	0.00505	0.00707	CcSEcCtD
Bendroflumethiazide—CA2—retina—acquired immunodeficiency syndrome	0.00504	0.0176	CbGeAlD
Bendroflumethiazide—CA1—bone marrow—acquired immunodeficiency syndrome	0.00504	0.0176	CbGeAlD
Bendroflumethiazide—CA1—spinal cord—acquired immunodeficiency syndrome	0.00501	0.0175	CbGeAlD
Bendroflumethiazide—Purpura—Delavirdine—acquired immunodeficiency syndrome	0.00498	0.00698	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Saquinavir—acquired immunodeficiency syndrome	0.00491	0.00689	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Zidovudine—acquired immunodeficiency syndrome	0.00484	0.00678	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Indinavir—acquired immunodeficiency syndrome	0.00478	0.0067	CcSEcCtD
Bendroflumethiazide—Thirst—Ritonavir—acquired immunodeficiency syndrome	0.00467	0.00654	CcSEcCtD
Bendroflumethiazide—Polyuria—Lamivudine—acquired immunodeficiency syndrome	0.00464	0.00651	CcSEcCtD
Bendroflumethiazide—TPMT—brain—acquired immunodeficiency syndrome	0.00457	0.016	CbGeAlD
Bendroflumethiazide—Hypokalaemia—Efavirenz—acquired immunodeficiency syndrome	0.00457	0.0064	CcSEcCtD
Bendroflumethiazide—CA1—lung—acquired immunodeficiency syndrome	0.00456	0.0159	CbGeAlD
Bendroflumethiazide—Pancreatitis—Indinavir—acquired immunodeficiency syndrome	0.0045	0.00631	CcSEcCtD
Bendroflumethiazide—Thirst—Saquinavir—acquired immunodeficiency syndrome	0.00449	0.00629	CcSEcCtD
Bendroflumethiazide—CA2—skin of body—acquired immunodeficiency syndrome	0.00443	0.0155	CbGeAlD
Bendroflumethiazide—TPMT—lymph node—acquired immunodeficiency syndrome	0.00442	0.0154	CbGeAlD
Bendroflumethiazide—Orthostatic hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00439	0.00615	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Delavirdine—acquired immunodeficiency syndrome	0.00432	0.00606	CcSEcCtD
Bendroflumethiazide—Thirst—Lamivudine—acquired immunodeficiency syndrome	0.00429	0.00601	CcSEcCtD
Bendroflumethiazide—CA4—digestive system—acquired immunodeficiency syndrome	0.00427	0.0149	CbGeAlD
Bendroflumethiazide—Pancreatitis—Efavirenz—acquired immunodeficiency syndrome	0.00425	0.00596	CcSEcCtD
Bendroflumethiazide—KCNMA1—brain—acquired immunodeficiency syndrome	0.00425	0.0148	CbGeAlD
Bendroflumethiazide—CA1—nervous system—acquired immunodeficiency syndrome	0.00423	0.0148	CbGeAlD
Bendroflumethiazide—KCNMA1—lymph node—acquired immunodeficiency syndrome	0.00411	0.0143	CbGeAlD
Bendroflumethiazide—Pancreatitis—Delavirdine—acquired immunodeficiency syndrome	0.00407	0.0057	CcSEcCtD
Bendroflumethiazide—CA4—blood—acquired immunodeficiency syndrome	0.00407	0.0142	CbGeAlD
Bendroflumethiazide—CA1—central nervous system—acquired immunodeficiency syndrome	0.00407	0.0142	CbGeAlD
Bendroflumethiazide—Orthostatic hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00406	0.00568	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Ritonavir—acquired immunodeficiency syndrome	0.004	0.0056	CcSEcCtD
Bendroflumethiazide—CA4—bone marrow—acquired immunodeficiency syndrome	0.00394	0.0137	CbGeAlD
Bendroflumethiazide—CA4—spinal cord—acquired immunodeficiency syndrome	0.00392	0.0137	CbGeAlD
Bendroflumethiazide—Anorexia—Amprenavir—acquired immunodeficiency syndrome	0.00389	0.00545	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Saquinavir—acquired immunodeficiency syndrome	0.00389	0.00545	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Saquinavir—acquired immunodeficiency syndrome	0.00385	0.00539	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Delavirdine—acquired immunodeficiency syndrome	0.00382	0.00536	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Nelfinavir—acquired immunodeficiency syndrome	0.00382	0.00535	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Ritonavir—acquired immunodeficiency syndrome	0.00376	0.00527	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Lamivudine—acquired immunodeficiency syndrome	0.00367	0.00515	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Didanosine—acquired immunodeficiency syndrome	0.00364	0.00511	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Saquinavir—acquired immunodeficiency syndrome	0.00362	0.00508	CcSEcCtD
Bendroflumethiazide—CA2—lymphoid tissue—acquired immunodeficiency syndrome	0.00358	0.0125	CbGeAlD
Bendroflumethiazide—CA4—lung—acquired immunodeficiency syndrome	0.00357	0.0125	CbGeAlD
Bendroflumethiazide—Decreased appetite—Amprenavir—acquired immunodeficiency syndrome	0.00355	0.00497	CcSEcCtD
Bendroflumethiazide—Anorexia—Didanosine—acquired immunodeficiency syndrome	0.00355	0.00497	CcSEcCtD
Bendroflumethiazide—CA2—digestive system—acquired immunodeficiency syndrome	0.00354	0.0124	CbGeAlD
Bendroflumethiazide—Erectile dysfunction—Ritonavir—acquired immunodeficiency syndrome	0.00354	0.00495	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Lamivudine—acquired immunodeficiency syndrome	0.00346	0.00484	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Saquinavir—acquired immunodeficiency syndrome	0.0034	0.00477	CcSEcCtD
Bendroflumethiazide—CA2—blood—acquired immunodeficiency syndrome	0.00337	0.0118	CbGeAlD
Bendroflumethiazide—Muscle spasms—Zidovudine—acquired immunodeficiency syndrome	0.00331	0.00464	CcSEcCtD
Bendroflumethiazide—CA4—nervous system—acquired immunodeficiency syndrome	0.0033	0.0115	CbGeAlD
Bendroflumethiazide—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.00328	0.00459	CcSEcCtD
Bendroflumethiazide—CA2—bone marrow—acquired immunodeficiency syndrome	0.00326	0.0114	CbGeAlD
Bendroflumethiazide—CA2—spinal cord—acquired immunodeficiency syndrome	0.00325	0.0113	CbGeAlD
Bendroflumethiazide—Decreased appetite—Didanosine—acquired immunodeficiency syndrome	0.00323	0.00453	CcSEcCtD
Bendroflumethiazide—CA1—brain—acquired immunodeficiency syndrome	0.00323	0.0113	CbGeAlD
Bendroflumethiazide—Anorexia—Nevirapine—acquired immunodeficiency syndrome	0.00319	0.00447	CcSEcCtD
Bendroflumethiazide—CA4—central nervous system—acquired immunodeficiency syndrome	0.00318	0.0111	CbGeAlD
Bendroflumethiazide—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.00317	0.00445	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.00316	0.00443	CcSEcCtD
Bendroflumethiazide—CA2—vagina—acquired immunodeficiency syndrome	0.00313	0.0109	CbGeAlD
Bendroflumethiazide—CA1—lymph node—acquired immunodeficiency syndrome	0.00312	0.0109	CbGeAlD
Bendroflumethiazide—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.00312	0.00437	CcSEcCtD
Bendroflumethiazide—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.00309	0.00433	CcSEcCtD
Bendroflumethiazide—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.00308	0.00432	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Indinavir—acquired immunodeficiency syndrome	0.00308	0.00431	CcSEcCtD
Bendroflumethiazide—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.00303	0.00425	CcSEcCtD
Bendroflumethiazide—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.00297	0.00417	CcSEcCtD
Bendroflumethiazide—CA2—lung—acquired immunodeficiency syndrome	0.00296	0.0103	CbGeAlD
Bendroflumethiazide—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.00293	0.0041	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.00291	0.00408	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.00282	0.00395	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.00281	0.00394	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00279	0.00391	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.00278	0.0039	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.00277	0.00388	CcSEcCtD
Bendroflumethiazide—Constipation—Stavudine—acquired immunodeficiency syndrome	0.00276	0.00387	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00275	0.00385	CcSEcCtD
Bendroflumethiazide—CA2—nervous system—acquired immunodeficiency syndrome	0.00274	0.00956	CbGeAlD
Bendroflumethiazide—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.00268	0.00375	CcSEcCtD
Bendroflumethiazide—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00267	0.00374	CcSEcCtD
Bendroflumethiazide—CA2—central nervous system—acquired immunodeficiency syndrome	0.00264	0.00921	CbGeAlD
Bendroflumethiazide—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.0026	0.00364	CcSEcCtD
Bendroflumethiazide—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00257	0.00361	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.00257	0.0036	CcSEcCtD
Bendroflumethiazide—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00257	0.0036	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.00256	0.00358	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00255	0.00357	CcSEcCtD
Bendroflumethiazide—CA4—brain—acquired immunodeficiency syndrome	0.00252	0.00881	CbGeAlD
Bendroflumethiazide—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.00249	0.00349	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.00248	0.00347	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.00244	0.00342	CcSEcCtD
Bendroflumethiazide—CA4—lymph node—acquired immunodeficiency syndrome	0.00244	0.00852	CbGeAlD
Bendroflumethiazide—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00242	0.0034	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00242	0.00339	CcSEcCtD
Bendroflumethiazide—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.0024	0.00336	CcSEcCtD
Bendroflumethiazide—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.0024	0.00336	CcSEcCtD
Bendroflumethiazide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00237	0.00332	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.00236	0.00331	CcSEcCtD
Bendroflumethiazide—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.00235	0.0033	CcSEcCtD
Bendroflumethiazide—Rash—Didanosine—acquired immunodeficiency syndrome	0.00235	0.00329	CcSEcCtD
Bendroflumethiazide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00234	0.00328	CcSEcCtD
Bendroflumethiazide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00232	0.00326	CcSEcCtD
Bendroflumethiazide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00232	0.00325	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00231	0.00324	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00229	0.00321	CcSEcCtD
Bendroflumethiazide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00228	0.0032	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.00227	0.00318	CcSEcCtD
Bendroflumethiazide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00225	0.00315	CcSEcCtD
Bendroflumethiazide—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00223	0.00313	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00222	0.00311	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00221	0.0031	CcSEcCtD
Bendroflumethiazide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00221	0.0031	CcSEcCtD
Bendroflumethiazide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00221	0.00309	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00218	0.00305	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.00214	0.00301	CcSEcCtD
Bendroflumethiazide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00214	0.003	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.00214	0.003	CcSEcCtD
Bendroflumethiazide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00214	0.00299	CcSEcCtD
Bendroflumethiazide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00213	0.00298	CcSEcCtD
Bendroflumethiazide—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00211	0.00296	CcSEcCtD
Bendroflumethiazide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00211	0.00296	CcSEcCtD
Bendroflumethiazide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00211	0.00295	CcSEcCtD
Bendroflumethiazide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.0021	0.00295	CcSEcCtD
Bendroflumethiazide—CA2—brain—acquired immunodeficiency syndrome	0.00209	0.00731	CbGeAlD
Bendroflumethiazide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.00208	0.00292	CcSEcCtD
Bendroflumethiazide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00206	0.00289	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00206	0.00288	CcSEcCtD
Bendroflumethiazide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00205	0.00288	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.00205	0.00288	CcSEcCtD
Bendroflumethiazide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00204	0.00286	CcSEcCtD
Bendroflumethiazide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00204	0.00286	CcSEcCtD
Bendroflumethiazide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00204	0.00286	CcSEcCtD
Bendroflumethiazide—Rash—Stavudine—acquired immunodeficiency syndrome	0.00204	0.00285	CcSEcCtD
Bendroflumethiazide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00203	0.00285	CcSEcCtD
Bendroflumethiazide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00202	0.00284	CcSEcCtD
Bendroflumethiazide—CA2—lymph node—acquired immunodeficiency syndrome	0.00202	0.00706	CbGeAlD
Bendroflumethiazide—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00202	0.00283	CcSEcCtD
Bendroflumethiazide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00201	0.00282	CcSEcCtD
Bendroflumethiazide—Rash—Abacavir—acquired immunodeficiency syndrome	0.00201	0.00281	CcSEcCtD
Bendroflumethiazide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.002	0.00281	CcSEcCtD
Bendroflumethiazide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.002	0.00281	CcSEcCtD
Bendroflumethiazide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00199	0.00279	CcSEcCtD
Bendroflumethiazide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00196	0.00275	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.00196	0.00275	CcSEcCtD
Bendroflumethiazide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00192	0.0027	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00192	0.00269	CcSEcCtD
Bendroflumethiazide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00192	0.00269	CcSEcCtD
Bendroflumethiazide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.00191	0.00268	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.0019	0.00266	CcSEcCtD
Bendroflumethiazide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00189	0.00265	CcSEcCtD
Bendroflumethiazide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00187	0.00263	CcSEcCtD
Bendroflumethiazide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00187	0.00262	CcSEcCtD
Bendroflumethiazide—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00187	0.00262	CcSEcCtD
Bendroflumethiazide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00186	0.0026	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00183	0.00256	CcSEcCtD
Bendroflumethiazide—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.0018	0.00252	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00179	0.0025	CcSEcCtD
Bendroflumethiazide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00179	0.0025	CcSEcCtD
Bendroflumethiazide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00177	0.00248	CcSEcCtD
Bendroflumethiazide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00177	0.00248	CcSEcCtD
Bendroflumethiazide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00177	0.00248	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.00174	0.00244	CcSEcCtD
Bendroflumethiazide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00173	0.00242	CcSEcCtD
Bendroflumethiazide—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00171	0.0024	CcSEcCtD
Bendroflumethiazide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00169	0.00237	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00169	0.00237	CcSEcCtD
Bendroflumethiazide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00167	0.00234	CcSEcCtD
Bendroflumethiazide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00166	0.00233	CcSEcCtD
Bendroflumethiazide—Rash—Indinavir—acquired immunodeficiency syndrome	0.00165	0.00231	CcSEcCtD
Bendroflumethiazide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00164	0.00231	CcSEcCtD
Bendroflumethiazide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00163	0.00229	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00162	0.00226	CcSEcCtD
Bendroflumethiazide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00157	0.0022	CcSEcCtD
Bendroflumethiazide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00157	0.00219	CcSEcCtD
Bendroflumethiazide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00156	0.00219	CcSEcCtD
Bendroflumethiazide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00156	0.00218	CcSEcCtD
Bendroflumethiazide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00155	0.00218	CcSEcCtD
Bendroflumethiazide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00155	0.00217	CcSEcCtD
Bendroflumethiazide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00151	0.00211	CcSEcCtD
Bendroflumethiazide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.0015	0.0021	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00149	0.00209	CcSEcCtD
Bendroflumethiazide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00149	0.00209	CcSEcCtD
Bendroflumethiazide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00149	0.00208	CcSEcCtD
Bendroflumethiazide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00147	0.00205	CcSEcCtD
Bendroflumethiazide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00144	0.00202	CcSEcCtD
Bendroflumethiazide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00144	0.00202	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00144	0.00201	CcSEcCtD
Bendroflumethiazide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.0014	0.00196	CcSEcCtD
Bendroflumethiazide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00139	0.00195	CcSEcCtD
Bendroflumethiazide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00139	0.00195	CcSEcCtD
Bendroflumethiazide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00138	0.00193	CcSEcCtD
Bendroflumethiazide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00138	0.00193	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00137	0.00192	CcSEcCtD
Bendroflumethiazide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00134	0.00187	CcSEcCtD
Bendroflumethiazide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00133	0.00186	CcSEcCtD
Bendroflumethiazide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00132	0.00186	CcSEcCtD
Bendroflumethiazide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00132	0.00185	CcSEcCtD
Bendroflumethiazide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.0013	0.00182	CcSEcCtD
Bendroflumethiazide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00127	0.00179	CcSEcCtD
Bendroflumethiazide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00126	0.00177	CcSEcCtD
Bendroflumethiazide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00126	0.00177	CcSEcCtD
Bendroflumethiazide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00125	0.00175	CcSEcCtD
Bendroflumethiazide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00119	0.00167	CcSEcCtD
